We can't find the internet
Attempting to reconnect
26118.2 PFLS-LS
A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies
Zusammenfassung
A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies
Weitere Texte
Abstract
Capitalizing on programmable cell fate regulation, we present a high-content screening platform measuring the differentiation capacity of pluripotent stem cells in a rapid, non-disruptive and inexpensive manner, enabling identification of high-quality stem cells for commercial applications.
Beteiligte
Martin Fussenegger
Kontaktperson
fussenegger@bsse.ethz.ch
ETH Zürich department of biosystems science an D-BSSE Martin Fussenegger Mattenstrasse 26 4058 Basel BS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2018-02-28
- Enddatum
- 2019-08-31
- Bewilligte Gesamtkosten
- CHF 336936.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%